Amgen moved up less than 1% today. The market isn't being very decisive in its valuation of Biotechnology company.
Amgen doesn't seem to be at a very clear reversal point in either direction. AMGN hasn't established a very clear directional momentum over the last few months. So it's not clear exactly where it's going. AMGN might find some support at the 287.7 level, buyers might push the price back up from here. But it's not very clear what will happen.
The analysts feel fairly neutral on the prospects for Amgen but a little more positive than negative. The current Analysts Sentiment Score is 49.07. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. Raymond James initiated a rating of Market Perform on 2024-03-28. On 2024-02-07 there was a downgrade announced by SVB Leerink from Outperform to Market Perform and dropped their 1 year price target to $318.00 which is down from $324.00. On 2024-02-07 The Goldman Sachs Group increased their price target by 11.82% to $350.00. Royal Bank of Canada gave a boost to their price target and moved to $329.00 from $303.00 on 2024-02-07. Morgan Stanley announced a lowering of their price target to $278.00 from $281.00 on 2024-02-07. Leerink Partnrs downgraded from Outperform to Market Perform on 2024-02-07. Oppenheimer reiterated a rating of Outperform on 2024-02-01 and added a price target of $350.00. On 2024-01-29 UBS Group lowered their price target by -0.32% to $314.00. Daiwa Capital Markets upgraded from Neutral to Buy on 2023-12-21 and also increased their price target by 21.21% to $320.00. BMO Capital Markets upgraded from Market Perform to Outperform on 2023-12-19 and also increased their price target by 13.99% to $326.00.
Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
---|---|---|---|---|---|
AMGN | 49.07 | 123.95 | -82.73 | 64.94 | -8.01 |
Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
---|---|---|
AMGN | 0.00 | 0.00 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
---|---|---|---|---|---|
AMGN | 1.91 | %1.2 | 2.6 | 0.66 | 6420000 |
Segment | Count | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest | Analysts Ratings ? |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biotechnology | 104 | 0.64 | -1.10 | -10.07 | 0.06 | 41.32 | 16.41 | 37.26 | 33.18 | 13.74 | 12.82 | -13905.94 | -11063.75 | 3.37 | 24.04 | 9.58 | 68.57 |
Healthcare | 247 | 0.43 | -0.34 | -8.37 | -2.85 | 27.18 | 5.24 | 41.55 | 31.33 | 10.68 | 11.04 | -12888.05 | -11534.39 | 4.96 | 17.31 | 6.93 | 48.52 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
Ticker | Social Sentiment(1-10) |
---|---|
AMGN |
Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CVS | CVS HEALTH CORPORATION | 0.68 | -0.22 | -3.52 | -15.56 | -9.12 | -1.18 | -8.05 | 70 | 11.61 | 7.61 | 9.77 | -377.07 | -10006.54 | 0 | 0 | 1.25794 |
GILD | Gilead Sciences Inc | 0.68 | 0.23 | -2.29 | -10.24 | -16.30 | -16.66 | -21.70 | 57 | -5.60 | -7.17 | -15.40 | -9536.28 | -2150.73 | 0 | 0 | 2.84781 |
JNJ | Johnson & Johnson | 0.62 | -0.46 | -2.00 | -7.38 | -7.72 | -1.92 | -10.34 | 45 | 3.10 | 2.75 | 0.68 | -1746.11 | -2048.92 | 0 | 0 | 0.455404 |
ABBV | ABBVIE INC. | 0.58 | -4.58 | -4.93 | -11.70 | -4.76 | 9.93 | 7.22 | 52 | 152.90 | 25.91 | 34.43 | 0.00 | -36710.95 | 0 | 0 | 2.04137 |
MDLZ | Mondelez International, I | 0.55 | -0.27 | 1.73 | 1.22 | -7.75 | 7.56 | -4.35 | 35 | 0.99 | 2.18 | 2.65 | -5260.01 | -1380.41 | 0 | 0 | 1.76038 |
MMM | 3M Company | 0.54 | 0.46 | -0.85 | -2.33 | -4.25 | 3.59 | -12.82 | 96 | -0.14 | -1.59 | -5.04 | -1246.92 | -9849.27 | 100 | 0 | 2.45691 |
BMY | Bristol-Myers Squibb Co. | 0.52 | 0.34 | -8.73 | -15.36 | -7.85 | -15.33 | -33.66 | 46 | -6.34 | -24.50 | -64.89 | -1106.62 | -1553.74 | 0 | 0 | 1.50693 |
PEP | PepsiCo, Inc. | 0.51 | -0.62 | -0.50 | 1.50 | 2.26 | 8.78 | -7.44 | 55 | -8.41 | -13.18 | -14.67 | -12681.80 | -1779.27 | 0 | 0 | 2.26552 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.